Video

Dr. Gieschen on Standard Approaches to Radiation Therapy in Prostate Cancer

Holger L. Gieschen, MD, assistant professor, University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses standard approaches to radiation therapy in prostate cancer.

Holger L. Gieschen, MD, assistant professor, University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses standard approaches to radiation therapy in prostate cancer.

There are many approaches in terms of radiation delivery, explains Gieschen. Standard external beam treatment is used over a longer period of time, whereas shorter courses of radiation can be given over a duration of 5.5 weeks. Selecting the right method should be individualized to each patient and the state of their disease, he adds. Patient preferences and expectations should also be factored into a treating physician’s decision.

In prostate cancer, radiation can be combined with androgen deprivation therapy (ADT). This approach is most appropriate in intermediate- and poor-risk populations, explains Gieschen. Patients with low-risk disease do not need the addition of ADT. Conversely, ADT should always be incorporated into the treatment course of a patient with high-risk disease if there are no contraindications that state otherwise.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine